Article
MicroRNA-21 Coordinates Human Multipotent Cardiovascular Progenitors Therapeutic Potential
28 Jul 2014
Abstract excerpt
Published clinical trials in patients with ischemic diseases show limited benefit of adult stem cell-based therapy, likely due to their restricted plasticity and commitment toward vascular cell lineage. We aim to uncover the potent regenerative ability of MesP1/stage-specific embryonic antigen 1 (SSEA-1)-expressing cardiovascular progenitors enriched from human embryonic stem cells (hESCs). Injection of only...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
